Gujarat Kidney IPO Details
Gujarat Kidney IPO Review & Key Points
- Review:
Gujarat Kidney IPO Market Lot
The Gujarat Kidney IPO minimum market lot is 128 shares with ā¹14,592 application amount. The retail investors can apply up-to 13 lots with 1,664 shares of ā¹1,89,696 amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 128 | ā¹14,592 |
| Retail Maximum | 13 | 1,664 | ā¹1,89,696 |
| S-HNI Minimum | 14 | 1,792 | ā¹2,04,288 |
| S-HNI Maximum | 68 | 8,704 | ā¹9,92,256 |
| B-HNI Minimum | 69 | 8,832 | ā¹10,06,848 |
IPO Reservation
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | 87,73,120 Shares | -% |
| QIB (Ex. Anchor) | – Shares | 75% |
| NII Shares Offered | – Shares | 15% |
| Retail Shares Offered | – Shares | 10% |
Gujarat Kidney IPO Anchor Investors
Gujarat Kidney IPO Dates
The Gujarat Kidney IPO date is December 22 and the close date is December 24. The Gujarat Kidney IPO allotment will be finalized on December 26 and the IPO listing on December 30.
| IPO Open Date: | December 22, 2025 |
| IPO Close Date: | December 24, 2025 |
| Basis of Allotment: | December 26, 2025 |
| Refunds: | December 29, 2025 |
| Credit to Demat Account: | December 29, 2025 |
| IPO Listing Date: | December 30, 2025 |
| IPO Bidding Cut-off Time: | December 24, 2025 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Dr. Pragnesh Yashwantsinh Bharpoda, Dr. Bhartiben Pragnesh Bharpoda, Dr. Yashwantsingh Motisinh Bharpoda and Anitaben Yashwantsinh Bharpoda.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 5,68,43,250 | 99.10% |
| Promoter Holding Post Issue | 7,88,43,250 | 71.45% |
Objects of the Issue & Utilisation of proceeds
| Purpose | Crores |
| Proposed acquisition of Parekhs Hospital at Ahmedabad. | ā¹77.00 |
| Part-payment of purchase consideration for the already acquired āAshwini Medical Centreā. | ā¹12.40 |
| Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara. | ā¹30.10 |
| Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital in Vadodara location. | ā¹6.83 |
| Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company | ā¹1.20 |
| Funding inorganic growth through unidentified acquisitions and General Corporate Purposes. | ā¹- |
| Acquisition of additional shareholding in the subsidiary namely āHarmony Medicare Private Limitedā at Bharuch | ā¹10.78 |
About Gujarat Kidney IPO
Gujarat Kidney and Super Speciality Limited (GKASSL), founded in 2019, is one of the leading companies that provides multispeciality healthcare services. The company has multiple hospitals situated across Gujarat, India. Its main services include Secondary Care Services and Tertiary Care Services. Internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology are some of the medical care offered by the company.
The business runs 7 multispeciality hospitals and four pharmacies. Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital (Bharuch), Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand) are some of the hospitals operated by the company.
Gujarat Kidney IPO Company Financial Report
Amount ā¹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ā¹0.00 | ā¹0.01 | ā¹0.01 | ā¹3.87 |
| 2024 | ā¹5.48 | ā¹3.21 | ā¹1.71 | ā¹20.53 |
| 2025 | ā¹40.40 | ā¹27.63 | ā¹9.50 | ā¹55.34 |
| June 2025 | ā¹15.27 | ā¹7.78 | ā¹5.40 | ā¹61.59 |
Gujarat Kidney IPO Valuation – FY2025
Check Gujarat Kidney IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 36.61% |
| ROCE: | 37.65% |
| EBITDA Margin: | 41.12% |
| PAT Margin: | 23.61% |
| Debt to equity ratio: | 0.15 |
| Earning Per Share (EPS): | ā¹1.85 (Basic) |
| Price/Earning P/E Ratio: | NA |
| Return on Net Worth (RoNW): | 36.61% |
| Net Asset Value (NAV): | ā¹5.04 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Yatharth Hospital & Trauma Care Services Limited | 14.72 | 55.84 | 8.13% | 166.62 | 880.49 Cr. |
| GPT Healthcare Limited | 6.08 | 24.51 | 20.14% | 30.21 | 407.09 Cr. |
| KMC Speciality Hospitals (India) Ltd | 1.31 | 52.60 | 13.04% | 10.08 | 231.60 Cr. |
IPO Lead Managers aka Merchant Bankers
- Nirbhay Capital Services Private Limited
Company Address
Gujarat Kidney and Super Speciality Limited
Plot No. 1, City Sarve No. 1537/A,
Jetalpur Road, Gokak Mill Compound,
Alkapuri, Vadodara ā 390 020, Gujarat
Phone: +91 265 298 4800
Email: [email protected]
Website: https://www.gujaratsuperspecialityhospital.com/
IPO Registrar
MUFG Intime India Pvt. Ltd.
Phone: +91-22-4918 6270
Email: [email protected]
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
Gujarat Kidney IPO FAQs
What is Gujarat Kidney IPO?
When Gujarat Kidney IPO will open for subscription?
What is Gujarat Kidney IPO Investors Portion?
How to Apply the Gujarat Kidney IPO?
What is Gujarat Kidney IPO Issue Size?
What is Gujarat Kidney IPO Price Band?
What is Gujarat Kidney IPO Lot Size?
What is the Gujarat Kidney IPO Allotment Date?
What is the Gujarat Kidney IPO Listing Date?
Note: The Gujarat Kidney IPO price band and date are officially announced. The (Gujarat Kidney IPO grey market premium) will be added to the IPO GMP page as it will start).





One Response
Can I apply for Gujarat Kidney IPO ?